Related Experiment Video
Updated: Mar 7, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
Physicians' Experiences as Patients with Statin Side Effects: A Case Series
Hayley J Koslik1, Athena Hathaway Meskimen1, Beatrice Alexandra Golomb2
1Department of Medicine, University of California, San Diego, 9500 Gilman Drive #0995, La Jolla, CA, 92093-0995, USA.
Drug Safety - Case Reports
|February 21, 2017
Summary
Physicians experiencing statin adverse effects (AEs) reported significant impacts on their quality of life and professional practice. Personal AE experiences altered their attitudes toward statin use and patient care.
Area of Science:
- Cardiology
- Neurology
- Endocrinology
- Pharmacology
Background:
- Physicians are frequently prescribed statins, yet the impact of statin adverse effects (AEs) on them is understudied.
- Understanding physician experiences with statin AEs is crucial for patient care and physician well-being.
Purpose of the Study:
- To assess the character and impact of statin AEs in physicians.
- To determine if personal experience with AEs modifies physicians' attitudes toward statin therapy.
Main Methods:
- Seven active or retired physicians shared their experiences with statin AEs.
- Data collected included AE characteristics, physician-patient interactions, and impact on professional life.
- Physicians reported on how their experiences altered their views on statin use.
Main Results:
- AEs affected multiple quality-of-life domains, including muscle pain, fatigue, neuropathy, cognitive issues, and glucose intolerance.
- Five physicians experienced professional repercussions due to AEs.
- Five physicians encountered dismissive attitudes from their own healthcare providers.
- Personal experiences with AEs altered physicians' understanding and attitudes toward statin therapy.
Conclusions:
- Statin AEs can profoundly impact physicians' lives, affecting their professional capacity and patient interactions.
- Physicians' personal experiences with AEs can lead to a nuanced perspective on statin prescribing.
- Healthcare providers should be attentive to potential AEs in all patients, including fellow physicians.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:26Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
319
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
319
01:27Coronary Artery Disease V: Interprofessional Care
357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
285
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
285
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
245
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
245